{"nctId":"NCT00317226","briefTitle":"Long Term Safety Study of (VIT45) Extension Study: Treatment of Anemia in Non-Dialysis Dependent Chronic Kidney Disease","startDateStruct":{"date":"2005-06"},"conditions":["Anemia"],"count":145,"armGroups":[{"label":"Ferric Carboxymaltose (FCM)","type":"EXPERIMENTAL","interventionNames":["Drug: Ferric Carboxymaltose (FCM)"]}],"interventions":[{"name":"Ferric Carboxymaltose (FCM)","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Subjects who completed or discontinued Protocol 1VIT04004\n\nExclusion Criteria:\n\n* Known hypersensitivity reaction to VIT-45\n* Anemia not related to CKD\n* Chronic, serious infection\n* Recent IV iron other than study drug in past 12 weeks\n* Recent blood loss within the last 12 weeks\n* Need for surgery or dialysis\n* Female subjects who are pregnant or lactating","healthyVolunteers":false,"sex":"ALL","minimumAge":"12 Years","stdAges":["CHILD","ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Incidence of Treatment-emergent Adverse Events","description":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"84","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":23,"n":127},"commonTop":["Odema peripheral","Urinary tract infection","Hypertension"]}}}